PT3653620T - Novos derivados heteroarilamida como inibidores seletivos de histona desacetilases 1 e 2 (hdac1-2) - Google Patents

Novos derivados heteroarilamida como inibidores seletivos de histona desacetilases 1 e 2 (hdac1-2)

Info

Publication number
PT3653620T
PT3653620T PT187897772T PT18789777T PT3653620T PT 3653620 T PT3653620 T PT 3653620T PT 187897772 T PT187897772 T PT 187897772T PT 18789777 T PT18789777 T PT 18789777T PT 3653620 T PT3653620 T PT 3653620T
Authority
PT
Portugal
Prior art keywords
hdac1
selective inhibitors
amide derivatives
histone deacetylases
heteroaryl amide
Prior art date
Application number
PT187897772T
Other languages
English (en)
Original Assignee
Medibiofarma S L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medibiofarma S L filed Critical Medibiofarma S L
Publication of PT3653620T publication Critical patent/PT3653620T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
PT187897772T 2017-07-10 2018-07-09 Novos derivados heteroarilamida como inibidores seletivos de histona desacetilases 1 e 2 (hdac1-2) PT3653620T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17382447 2017-07-10

Publications (1)

Publication Number Publication Date
PT3653620T true PT3653620T (pt) 2022-04-22

Family

ID=59315557

Family Applications (1)

Application Number Title Priority Date Filing Date
PT187897772T PT3653620T (pt) 2017-07-10 2018-07-09 Novos derivados heteroarilamida como inibidores seletivos de histona desacetilases 1 e 2 (hdac1-2)

Country Status (21)

Country Link
US (1) US11241428B2 (pt)
EP (1) EP3653620B9 (pt)
JP (1) JP7026787B2 (pt)
KR (1) KR102574135B1 (pt)
CN (1) CN111051300B (pt)
AU (1) AU2018300123B2 (pt)
BR (1) BR112020000564A2 (pt)
CA (1) CA3069273A1 (pt)
DK (1) DK3653620T3 (pt)
EA (1) EA039144B1 (pt)
ES (1) ES2911040T3 (pt)
HR (1) HRP20220472T1 (pt)
HU (1) HUE058353T2 (pt)
LT (1) LT3653620T (pt)
MX (1) MX2020000349A (pt)
PL (1) PL3653620T3 (pt)
PT (1) PT3653620T (pt)
RS (1) RS63156B1 (pt)
SI (1) SI3653620T1 (pt)
WO (1) WO2019012172A1 (pt)
ZA (1) ZA202000727B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114524799B (zh) * 2022-03-11 2023-05-26 沈阳药科大学 一种hdac抑制剂及其制备方法和用途
EP4306106A1 (en) * 2022-07-14 2024-01-17 Universidade de Aveiro Nitro-containing compounds, compositions and uses thereof
CN115463215A (zh) * 2022-07-26 2022-12-13 苏州大学 Hdac9及其抑制剂的新用途
WO2024030659A1 (en) 2022-08-05 2024-02-08 Tango Therapeutics, Inc. An hdac inhibitor for treating cancer with a modified stk11 activity or expression
CN115304513A (zh) * 2022-08-25 2022-11-08 湖北科技学院 具有抗炎活性的查尔酮类衍生物及其合成方法和应用
CN115368277B (zh) * 2022-09-15 2024-03-29 华侨大学 一种含异羟肟酸结构的联苯类化合物及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006312084A1 (en) 2005-11-03 2007-05-18 Merck Sharp & Dohme Corp. Substituted nicotinamide compounds
AU2007243519A1 (en) 2006-04-26 2007-11-08 Merck Sharp & Dohme Corp. Disubstituted aniline compounds
WO2009005638A2 (en) 2007-06-27 2009-01-08 Merck & Co., Inc. Pyridyl and pyrimidinyl derivatives as histone deacetylase inhibitors
CN102459159A (zh) 2009-06-08 2012-05-16 吉利德科学股份有限公司 烷酰基氨基苯甲酰胺苯胺hdac抑制剂化合物
WO2016057779A2 (en) * 2014-10-08 2016-04-14 Acetylon Pharmaceuticals, Inc. Induction of gata2 by hdac1 and hdac2 inhibitors
RU2720678C2 (ru) * 2015-07-02 2020-05-12 Байомарин Фармасьютикал Инк. Ингибиторы гистондеацетилазы
US9603950B1 (en) 2015-10-25 2017-03-28 Institute Of Nuclear Energy Research Compounds of imaging agent with HDAC inhibitor for treatment of Alzheimer syndrome and method of synthesis thereof

Also Published As

Publication number Publication date
HRP20220472T1 (hr) 2022-05-27
PL3653620T3 (pl) 2022-06-20
KR102574135B1 (ko) 2023-09-01
EA039144B1 (ru) 2021-12-09
EA202090259A1 (ru) 2020-05-25
JP7026787B2 (ja) 2022-02-28
MX2020000349A (es) 2020-08-17
ES2911040T3 (es) 2022-05-17
US11241428B2 (en) 2022-02-08
SI3653620T1 (sl) 2022-05-31
EP3653620A1 (en) 2020-05-20
HUE058353T2 (hu) 2022-07-28
EP3653620B1 (en) 2022-02-02
WO2019012172A1 (es) 2019-01-17
LT3653620T (lt) 2022-05-10
CN111051300B (zh) 2022-12-23
CN111051300A (zh) 2020-04-21
RS63156B1 (sr) 2022-05-31
JP2020527173A (ja) 2020-09-03
AU2018300123A1 (en) 2020-02-13
CA3069273A1 (en) 2019-01-17
ZA202000727B (en) 2022-07-27
US20200138808A1 (en) 2020-05-07
KR20200038473A (ko) 2020-04-13
BR112020000564A2 (pt) 2020-07-21
AU2018300123B2 (en) 2022-03-17
EP3653620B9 (en) 2022-03-23
DK3653620T3 (da) 2022-03-28

Similar Documents

Publication Publication Date Title
ZA202000727B (en) New heteroaryl amide derivatives as selective inhibitors of histone deacetylases 1 and 2 (hdac1-2)
HK1252489A1 (zh) 組蛋白去乙酰化酶抑制劑及其組合物和使用方法
HK1251939A1 (zh) 作為組蛋白脫乙酰酶6抑制劑的1,3,4-噁二唑酰胺衍生物化合物及含有其的藥物組合物
EP3590931A4 (en) AMIDE DERIVATIVE INHIBITOR, PROCESS OF PREPARATION AND APPLICATION
EP3475275A4 (en) 3-ARYL- AND HETEROARYL-SUBSTITUTED 5-TRIFLUORMETHYLOXADIAZOLES AS HISTONE DEACETYLASE 6 (HDAC6) INHIBITORS
IL267090A (en) Amine-disubstituted heterocyclic compounds as ehmt2 inhibitors and methods of using them
EP3114109A4 (en) Inhibitors of histone lysine specific demethylase (lsd1) and histone deacetylases (hdacs)
EP3624804A4 (en) HISTONE DEACETYLASIS INHIBITORS (HDACS)
IL249339A0 (en) Histone deacetylase inhibitors and compositions and methods of using them
HK1252487A1 (zh) 組蛋白去乙酰化酶抑制劑及其組合物和使用方法
IL274504A (en) 2ACSS inhibitors and methods of their use
IL274973A (en) History of 4,2,1-oxadiazole as histone deacetylase inhibitors
PT3297992T (pt) Compostos derivados de alquilo heterocíclicos como inibidores seletivos da histona desacetilase e composições farmacêuticas que compreendem os mesmos
EP3684756A4 (en) SYNTHESIS OF N-ACETYLCYSTEIN AMIDE AND ITS DERIVATIVES
IL279940A (en) Histone deacetylase inhibitors
EP3458444A4 (en) HISTON DEACETYLASE 6 HEMMER AND USE THEREOF
ZA202002786B (en) Indole (sulfomyl) n-hydroxy benzamide derivatives as selective hdac inhibitors
CZ34382U1 (cs) Amidové deriváty karboxymethylchitosanu